Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMPIN vs RIOCIGUAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMPIN vs RIOCIGUAT: Safety Overview

Metric RIFAMPIN RIOCIGUAT
Total FAERS Reports 13,347 18,268
Deaths Reported 1,439 5,380
Death Rate 10.8% 29.5%
Hospitalizations 5,764 7,951
Average Patient Age 51.7 yrs 63.9 yrs
% Female Patients 47.8% 70.6%
FDA Approval Date Approved Prior to Jan 1, 1982 Oct 8, 2013
Manufacturer Hikma Pharmaceuticals USA Inc. Bayer HealthCare Pharmaceuticals Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription